top of page

Target Audience:

This activity has been designed to meet the educational needs of physicians, physician assistants and nurse practitioners involved in the care of patients with chronic liver disease (CLD) and gastrointestinal (GI) disorders.

Program Overview:

The accredited inaugural live conference will deliver focused, educational updates highlighting clinically relevant advances in the management of patients with CLD and GI disorders. The conference will feature an interactive format to enhance the educational impact. Internationally renowned gastroenterologists and hepatologists will lead the development of educational content and will serve as program faculty. The faculty will review state-of-the-art developments in CLD and GI disorders.

Educational Objectives:

Upon completion of this educational activity, participants should be able to:

  • Describe current screening, diagnosis, and management options for patients with chronic liver disease (CLD) and gastrointestinal (GI) disorders.

  • Apply optimal treatment strategies for patients with CLD and GI disorders.

  • Compare and contrast currently available treatment modalities for CLD and GI disorders.

 

Physician Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and Focus Medical Communications (Focus), in collaboration with Allied Digestive Health (ADH). Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation:

Purdue University College of Pharmacy designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits   . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

All other healthcare providers will receive a certificate of participation indicating that this activity is designated for 4.5 AMA PRA Category 1 Credits   .

Disclosure of Relevant Financial Relationships:

To ensure compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Purdue University requires that all individuals in a position to control the content of an educational activity disclose all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflicts of interest identified are thoroughly assessed by Purdue University to ensure fair balance, scientific rigor, and accepted patient care recommendations of the educational activity.

 

All relevant conflicts of interest have been mitigated prior to the start of the activity.

 

None of the planners, reviewers, Focus Medical Communications staff, Allied Digestive Health staff, and Purdue University College of Pharmacy staff have relevant financial relationships with ineligible companies to disclose unless listed below.

 

Fee information:

Please find registration information for this educational activity under https://www.adhconference.org/event-details/enhancing-gi-liver-clinical-care-conference.

TM

TM

Accreditation

Jointly provided by Purdue University College of Pharmacy and Focus Medical Communications,

in collaboration with Allied Digestive Health.

Supported by educational grants from Madrigal Pharmaceuticals and Salix Pharmaceuticals.

Purdue Logo_2020.png
bottom of page